Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
Author(s) -
Philip Wenzel,
Maike Knorr,
Sabine Kossmann,
Jan A. Stratmann,
Michael Hausding,
Swenja Schuhmacher,
Susanne Karbach,
Melanie Schwenk,
Nir Yogev,
Eberhard Schulz,
Matthias Oelze,
Stephan Grabbe,
Helmut Jonuleit,
Christian Becker,
Andreas Daiber,
Ari Waisman,
Thomas Münzel
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.034470
Subject(s) - medicine , angiotensin ii , pathophysiology of hypertension , lysozyme , endothelial dysfunction , cardiology , vascular smooth muscle , vascular disease , endocrinology , blood pressure , smooth muscle , biochemistry , chemistry
Angiotensin II (ATII), a potent vasoconstrictor, causes hypertension, promotes infiltration of myelomonocytic cells into the vessel wall, and stimulates both vascular and inflammatory cell NADPH oxidases. The predominant source of reactive oxygen species, eg, vascular (endothelial, smooth muscle, adventitial) versus phagocytic NADPH oxidase, and the role of myelomonocytic cells in mediating arterial hypertension have not been defined yet.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom